Hypoperfusion in Supramarginal and Orbital Gyrus, Position Discrimination Test, and Microsaccades as a Predictor of Pisa Syndrome in Parkinson's Disease
- PMID: 38846136
- PMCID: PMC11156507
- DOI: 10.1155/2024/5550362
Hypoperfusion in Supramarginal and Orbital Gyrus, Position Discrimination Test, and Microsaccades as a Predictor of Pisa Syndrome in Parkinson's Disease
Abstract
Patients with Parkinson's disease (PD) experience significantly reduced quality of life when PD is complicated with Pisa syndrome (PS). PS is a postural abnormality associated with a lateral bending of the trunk, causing the patient to lean to one side. Microsaccades during fixation are transmitted to the visual cortex, and this gaze movement may be impaired in PD. We aimed to detect presymptomatic signs of PS. We enrolled 50 patients with PD without dementia and investigated the visual systems in patients with concurrent PD and PS based on a Romberg ratio of<1.0. Gaze analysis, pupil diameter, stabilization tests, neuropsychological tests, and cerebral perfusion scintigraphy were reviewed and statistically analyzed. Two years later, we divided the patients into three groups as follows: PISA++ (patients who had PS at enrollment), PISA-+ (patients without PS that developed PS during the 2-year period), and PISA-- (patients without PS that did not develop PS during the 2-year period). The PISA-+ group exhibited a significantly higher daily levodopa dose and longer fixations, as well as lower position discrimination, Wechsler Adult Intelligence Scale-Third Edition blocking, and blood flow in the left supramarginal and orbital gyri than that in the PISA-- group. The PISA++ group showed a significantly longer fixation time and lower Mini-Mental State Examination score, Romberg ratio of area, amplitude, velocity of microsaccades, and blood flow in the left precuneus and cuneus than that in the PISA-+ group. Before the onset of PS, hypoperfusion occurred in the correlative visual cortex and the position discrimination test. Patients with PS have reduced saccades and slow microsaccades.
Copyright © 2024 Asako Yoritaka et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest regarding the publication of this article. AY received speaker honoraria from Kyowa Kirin Co., Ltd., Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Eisai Pharmaceutical Co., Ltd. NH was an advisory member of Sumitomo Pharma Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., and Biogen Idec Japan Ltd., received lecture fees from Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., FP Pharmaceutical Corporation, Eisai Co., Ltd., and AbbVie GK, and received departmental endowments by commercial entities from Kyowa Kirin Co., Ltd., Nippon Boehringer Ingelheim, Co., Ltd., AbbVie GK, FP Pharmaceutical Corporation, Otsuka Pharmaceutical, Co., Ltd., Dai-Nippon Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Nihon Medi-Physics Co., Ltd., Asahi Kasei Medical Co., Ltd., Ono Pharmaceutical Co., Ltd., MiZ Co., Ltd., AbbVie GK, OHARA Pharmaceutical Co., Ltd., Nihon Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Boston Scientific Corporation, and Medtronic Inc.
Figures



Similar articles
-
Does Pisa syndrome affect upper limb function in patients with Parkinson's disease? An observational cross-sectional study.NeuroRehabilitation. 2018;42(2):143-148. doi: 10.3233/NRE-172274. NeuroRehabilitation. 2018. PMID: 29562562
-
Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations.Front Neurol. 2019 May 31;10:577. doi: 10.3389/fneur.2019.00577. eCollection 2019. Front Neurol. 2019. PMID: 31214112 Free PMC article.
-
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease.Mov Disord Clin Pract. 2022 Nov 14;10(1):64-73. doi: 10.1002/mdc3.13605. eCollection 2023 Jan. Mov Disord Clin Pract. 2022. PMID: 36704069 Free PMC article.
-
Pisa syndrome in Parkinson's disease: An integrated approach from pathophysiology to management.Mov Disord. 2016 Dec;31(12):1785-1795. doi: 10.1002/mds.26829. Epub 2016 Oct 25. Mov Disord. 2016. PMID: 27779784 Review.
-
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment.Lancet Neurol. 2016 Sep;15(10):1063-74. doi: 10.1016/S1474-4422(16)30173-9. Epub 2016 Aug 8. Lancet Neurol. 2016. PMID: 27571158 Review.
Cited by
-
Pisa Syndrome Secondary to Drugs: A Scope Review.Geriatrics (Basel). 2024 Jul 30;9(4):100. doi: 10.3390/geriatrics9040100. Geriatrics (Basel). 2024. PMID: 39195130 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources